Skip to main content
Top
Published in: Clinical Rheumatology 3/2015

01-03-2015 | Letter to the Editor

Anti-citrullinated peptide/protein antibodies in Palindromic rheumatism: comment on the article by Emad Y et al.

Authors: Sonia Cabrera-Villalba, Julio Ramírez, Jose Inciarte-Mundo, Raimon Sanmartí

Published in: Clinical Rheumatology | Issue 3/2015

Login to get access

Excerpt

Dear Editor: …
Literature
1.
go back to reference Emad Y, Anbar A, Abo-Elyoun I, El-Shaarawy N, Al-Hanafi H, Darwish H et al (2014) In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin Rheumatol. doi:10.1007/s10067-014-2569–3 PubMed Emad Y, Anbar A, Abo-Elyoun I, El-Shaarawy N, Al-Hanafi H, Darwish H et al (2014) In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin Rheumatol. doi:10.​1007/​s10067-014-2569–3 PubMed
2.
go back to reference Salvador G, Gomez A, Vinas O, Ercilla G, Canete JD, Munoz-Gomez J, Sanmarti R (2003) Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology (Oxford) 42:972–975CrossRef Salvador G, Gomez A, Vinas O, Ercilla G, Canete JD, Munoz-Gomez J, Sanmarti R (2003) Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology (Oxford) 42:972–975CrossRef
3.
go back to reference Sanmartí R, Cabrera-Villalba S, Gomez-Puerta JA, Ruiz-Esquide V, Hernández MV, Salvador G, Ramírez J, Viñas O, Cañete JD (2012) Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J Rheumatol 39:1929–1933CrossRefPubMed Sanmartí R, Cabrera-Villalba S, Gomez-Puerta JA, Ruiz-Esquide V, Hernández MV, Salvador G, Ramírez J, Viñas O, Cañete JD (2012) Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J Rheumatol 39:1929–1933CrossRefPubMed
4.
go back to reference Russell AS, Devani A, Maksymowych WP (2006) The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol 33:1240–1242PubMed Russell AS, Devani A, Maksymowych WP (2006) The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol 33:1240–1242PubMed
5.
go back to reference Khabbazi A, Hajialiloo M, Kolahi S, Soroosh M, Esalatmanesh K, Sharif S (2012) A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int J Rheum Dis 15:427–430CrossRefPubMed Khabbazi A, Hajialiloo M, Kolahi S, Soroosh M, Esalatmanesh K, Sharif S (2012) A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int J Rheum Dis 15:427–430CrossRefPubMed
6.
go back to reference Cabrera-Villalba S, Ramírez J, Salvador G, Ruiz-Esquide V, Hernández M.V, Inciarte-Mundo J, Gómez-Puerta JA, Cañete JD, Sanmartí R (2014) Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated peptide/protein antibody status. J Rheumatol, in press Cabrera-Villalba S, Ramírez J, Salvador G, Ruiz-Esquide V, Hernández M.V, Inciarte-Mundo J, Gómez-Puerta JA, Cañete JD, Sanmartí R (2014) Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated peptide/protein antibody status. J Rheumatol, in press
Metadata
Title
Anti-citrullinated peptide/protein antibodies in Palindromic rheumatism: comment on the article by Emad Y et al.
Authors
Sonia Cabrera-Villalba
Julio Ramírez
Jose Inciarte-Mundo
Raimon Sanmartí
Publication date
01-03-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2649-4

Other articles of this Issue 3/2015

Clinical Rheumatology 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.